HRT Financial’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.68M Buy
+49,245
New +$3.54M 0.01% 1339
2023
Q4
– Sell
-18,163
Closed -$864K – 2832
2023
Q3
$864K Buy
+18,163
New +$991K 0.01% 1082
2023
Q1
– Sell
-21,887
Closed -$1.54M – 2951
2022
Q4
$1.54M Sell
21,887
-23,999
-52% -$1.69M 0.02% 718
2022
Q3
$2.78M Buy
45,886
+32,091
+233% +$2.15M 0.03% 492
2022
Q2
$871K Buy
+13,795
New +$899K 0.01% 1048
2022
Q1
– Sell
-4,874
Closed -$349K – 3605
2021
Q4
$349K Sell
4,874
-24,328
-83% -$1.85M ﹤0.01% 2162
2021
Q3
$2.08M Buy
29,202
+21,816
+295% +$1.72M 0.01% 706
2021
Q2
$600K Buy
+7,386
New +$594K 0.01% 1606
2021
Q1
– Sell
-4,081
Closed -$309K – 3000
2020
Q4
$309K Sell
4,081
-10,261
-72% -$668K 0.01% 1273
2020
Q3
$709K Buy
+14,342
New +$809K 0.02% 723
2019
Q4
– Sell
-6,370
Closed -$540K – 1479
2019
Q3
$540K Buy
+6,370
New +$567K 0.03% 641

Other funds holding NGVT

HRT Financial's NGVT Position: Q2 2026 in Review

HRT Financial opened a new position in Ingevity (NGVT) in Q2 2026: 49,245 shares worth $3.68M. The stake represents 0.01% of the portfolio and ranks #1339 among its holdings. This is a return to the name: HRT Financial previously reported a position in NGVT as recently as Q3 2023.

HRT Financial first reported a position in NGVT in Q3 2019 and has held it in 11 quarters since. 316 funds tracked by Wall St. Rank hold NGVT as of Q2 2026.

  • HRT Financial held 49,245 shares of Ingevity worth $3.68M as of Q2 2026.
  • Ingevity was a new HRT Financial position in Q2 2026.
  • Ingevity made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1339 holding.
  • HRT Financial first reported a position in Ingevity in Q3 2019 and has held it in 11 quarters since.
  • 316 funds tracked by Wall St. Rank held Ingevity as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.